Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2025 Jul 31;14(7):2891-2892.
doi: 10.21037/tlcr-2025-524. Epub 2025 Jul 21.

Targeting arachidonic acid-modulated autophagy: a novel axis in crizotinib resistance

Shameer Tahir  1
Affiliations
Comment

Targeting arachidonic acid-modulated autophagy: a novel axis in crizotinib resistance

Shameer Tahir. Transl Lung Cancer Res. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-2025-524/coif). The author has no conflicts of interest to declare.

Comment on

Similar articles

See all similar articles

References

    1. Jie H, Lai H, Wang Z, et al. Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1 (+) or ALK (+) non-small cell lung cancer to crizotinib therapy. Transl Lung Cancer Res 2025;14:878-96. 10.21037/tlcr-2025-105 - DOI - PMC - PubMed
    1. Ouverney G, Hottz D, Robbs BK. Drug Resistance and Novel Targets for Cancer Therapy: An Overview of Recent Findings. Biomedicines 2024;12:816. 10.3390/biomedicines12040816 - DOI - PMC - PubMed
    1. Tang FH, Wong HYT, Tsang PSW, et al. Recent advancements in lung cancer research: a narrative review. Transl Lung Cancer Res 2025;14:975-90. 10.21037/tlcr-24-979 - DOI - PMC - PubMed
    1. Singh MP, Cho HJ, Kim JT, et al. Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma. Cancers (Basel) 2019;11:986. 10.3390/cancers11070986 - DOI - PMC - PubMed
    1. Janku F, Garrido-Laguna I, Petruzelka LB, et al. Novel therapeutic targets in non-small cell lung cancer. J Thorac Oncol 2011;6:1601-12. 10.1097/JTO.0b013e31822944b3 - DOI - PubMed

LinkOut - more resources